Large-scale testing (Phase 3)Study completedNCT02720094
What this trial is testing
Injectable Cabotegravir Compared to TDF/FTC For PrEP in HIV-Uninfected Men and Transgender Women Who Have Sex With Men
Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 4,570